Rapid Micro Biosystems, Inc. (RPID)

NASDAQ: RPID · Real-Time Price · USD

2.110

+0.050 (2.43%)

At close: Aug 5, 2026, 4:00 PM EDT

2.089

-0.021 (-0.98%)

After-hours: Aug 5, 2026, 6:36 PM EDT

Rapid Micro Biosystems Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	13.82	20.03	16.91	24.29	27.06	178.39
Short-Term Investments	9.13	18.27	33.82	67.77	81.58	15.11
Cash & Short-Term Investments	22.95	38.3	50.73	92.05	108.65	193.5
Cash Growth	-44.93%	-24.51%	-44.89%	-15.27%	-43.85%	329.26%
Accounts Receivable	6.37	3.13	7.52	5.53	5.37	5.01
Inventory	17.45	17.59	20.2	19.96	21.19	15.67
Other Current Assets	2.46	2.15	2.47	2.87	3.37	3.95
Total Current Assets	49.23	61.17	80.92	120.42	138.58	218.12
Net Property, Plant & Equipment	12.61	13.08	16.36	19.07	20.88	11.3
Long-Term Investments	-	-	-	2.91	29.79	9.97
Other Long-Term Assets	0.53	0.6	0.9	1.05	1.4	1.78
Total Assets	62.36	74.85	98.17	143.45	190.65	241.17

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	4.67	4.14	2.54	1.97	5.43	3.94
Accrued Expenses	6.5	8.32	7.22	9.91	8.15	10.92
Current Portion of Leases	1.32	1.3	1.21	1.13	0.77	-
Unearned Revenue	6.63	4.73	6.6	5.97	4.71	3.31
Total Current Liabilities	19.12	18.49	17.57	18.99	19.05	18.17
Long-Term Debt	19.05	18.9	-	-	-	-
Long-Term Leases	3.34	3.67	4.95	6.21	7.2	-
Other Long-Term Liabilities	0.46	0.58	0.3	0.26	0.23	2.02
Total Long-Term Liabilities	22.85	23.16	5.25	6.48	7.43	2.02
Total Liabilities	41.97	41.65	22.82	25.46	26.48	20.19

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	0.46	0.45	0.43	0.42	0.42	0.42
Additional Paid-in Capital	556.61	555.15	550.16	546.05	540.78	535.69
Accumulated Other Comprehensive Income	-0	0.01	0.04	-0.1	-1.11	-0.02
Retained Earnings	-536.67	-522.4	-475.27	-428.39	-375.92	-315.11
Total Common Shareholders' Equity	20.4	33.21	75.35	117.99	164.17	220.98
Shareholders' Equity	20.4	33.21	75.35	117.99	164.17	220.98
Total Liabilities & Equity	62.36	74.85	98.17	143.45	190.65	241.17

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	23.71	23.87	6.17	7.35	7.97	0
Net Cash (Debt)	-0.76	14.42	44.56	84.71	100.68	193.5
Net Cash Growth	-	-67.64%	-47.39%	-15.87%	-47.97%	854.74%
Net Cash Per Share	-0.02	0.32	1.02	1.97	2.37	9.78
Book Value	20.4	33.21	75.35	117.99	164.17	220.98
Book Value Per Share	0.45	0.74	1.73	2.74	3.87	11.17
Tangible Book Value	20.4	33.21	75.35	117.99	164.17	220.98
Tangible Book Value Per Share	0.45	0.74	1.73	2.74	3.87	11.17

SEC Filings: 10-K · 10-Q